Joanna Kesten
Overview
Explore the profile of Joanna Kesten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neale J, Kelly B, Braciszewski J, Kesten J, Lankenau S, Mayock P, et al.
Addiction
. 2025 Mar;
PMID: 40084416
No abstract available.
2.
Harrison C, Family H, Kesten J, Denford S, Scott J, Sabin C, et al.
Sex Transm Infect
. 2024 Nov;
PMID: 39542715
Objectives: Expanding delivery of oral pre-exposure prophylaxis (PrEP) to community pharmacies could improve access, aligning well with the UK government's goals to eliminate new HIV acquisitions by 2030. Using the...
3.
Archer A, May T, Bowers H, Kesten J, Tilden S, Abeysekera K, et al.
BMJ Open Gastroenterol
. 2024 Nov;
11(1).
PMID: 39537216
Objective: Liver disease is a growing cause of premature death in the UK. The National Health Service in England (NHS England) has funded regional early detection programmes through Community Liver...
4.
Denford S, Holt L, Essery R, Kesten J, Cabral C, Weston D, et al.
BMC Public Health
. 2024 Aug;
24(1):2217.
PMID: 39143472
Background: Inclusion in public health research of young people from low-income households and those from minority ethnic groups remains low. It is recognised that there is a need to change...
5.
Harrison C, Family H, Kesten J, Denford S, Scott A, Dawson S, et al.
J Int AIDS Soc
. 2024 Mar;
27(3):e26232.
PMID: 38494652
Introduction: Pre-exposure prophylaxis (PrEP) is an effective medication to reduce the risk of acquiring HIV. PrEP is available free of charge in the UK from sexual health clinics. Expanding PrEP...
6.
Kesten J, Hussey D, Lord C, Roberts L, Bayliss J, Erswell H, et al.
Harm Reduct J
. 2023 Aug;
20(1):114.
PMID: 37608267
Background: Skin and soft tissue infections (SSTI) among people who inject drugs (PWID) are a public health concern. This study aimed to co-produce and assess the acceptability and feasibility of...
7.
Carlisle V, Maynard O, Bagnall D, Hickman M, Shorrock J, Thomas K, et al.
Int J Environ Res Public Health
. 2023 Jan;
20(2).
PMID: 36674280
(1) The harm-reduction benefits of opioid agonist treatment (OAT) are well-established; however, the UK government's emphasis on "recovery" may be contributing to a high proportion of people leaving treatment and...
8.
Fisher H, Chantler T, Finn A, Kesten J, Hickman M, Letley L, et al.
Res Involv Engagem
. 2022 Apr;
8(1):16.
PMID: 35468845
Background: The English schools-based human papillomavirus (HPV) vaccination programme is routinely offered to all young people aged 12-13 years, to prevent cancers affecting the cervix, vulva, vagina, penis, anus and...
9.
Trickey A, Croxford S, Emanuel E, Ijaz S, Hickman M, Kesten J, et al.
Clin Infect Dis
. 2022 Feb;
75(6):1073-1077.
PMID: 35184173
Syringes with attached needles (termed fixed low dead space syringes [LDSS]) retain less blood following injection than syringes with detachable needles, but evidence on them reducing blood-borne virus transmission among...
10.
Kesten J, Ward Z, Hancock E, Ayres R, Neale J, Hussey D, et al.
Addiction
. 2020 Jun;
115(12):2407-2408.
PMID: 32533576
No abstract available.